OUR RESEARCH FOCUS
Our research group investigates the molecular mechanisms governing the fate of hematopoietic stem and progenitor cells in health and disease.
Healthy HSPCs generate the full spectrum of blood and immune cells through tightly regulated self-renewal and differentiation capacities.
Perturbations of these properties can lead to blood cancers, such as leukemia.
Recent News
Thank you!
Key events
September 2022
@Tremblay_Lab is launched on Twitter;
TREMBLAY LAB joins the Paul Albrechtsen Research Institute @ CancerCare Manitoba and the Department of Immunology, University of Manitoba.
​
January 2023
TREMBLAY LAB joins the Children’s Hospital Research Institute of Manitoba (CHRIM) - the first research facility dedicated exclusively to pediatric research in the prairie provinces.
October 2022
The TREMBLAY LAB website is officially launched!
March 2024
TREMBLAY LAB joins PROMISE - Pediatric research in Oncology in Manitoba: Innovation, Science & Excellence - the new research theme focused on cancers in children, adolescents and young adults.